(S)-N-(5-cyano-4-(3-methoxypyrrolidin-1-yl)pyridin-2-yl)-7-formyl-6-((3-oxomorpholino)methyl)-3,4-dihydro-1,8-naphthyridine-1(2H)-carboxamide

ID: ALA4571626

PubChem CID: 132156669

Max Phase: Preclinical

Molecular Formula: C26H29N7O5

Molecular Weight: 519.56

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CO[C@H]1CCN(c2cc(NC(=O)N3CCCc4cc(CN5CCOCC5=O)c(C=O)nc43)ncc2C#N)C1

Standard InChI:  InChI=1S/C26H29N7O5/c1-37-20-4-6-31(14-20)22-10-23(28-12-19(22)11-27)30-26(36)33-5-2-3-17-9-18(21(15-34)29-25(17)33)13-32-7-8-38-16-24(32)35/h9-10,12,15,20H,2-8,13-14,16H2,1H3,(H,28,30,36)/t20-/m0/s1

Standard InChI Key:  YLKSNLRSSLYYOT-FQEVSTJZSA-N

Molfile:  

 
     RDKit          2D

 38 42  0  0  0  0  0  0  0  0999 V2000
   38.3627   -4.9550    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.3627   -5.7722    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.0680   -6.1766    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   39.7732   -5.7722    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.7732   -4.9550    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.0680   -4.5423    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   39.0680   -3.7251    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.7757   -3.3165    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.6538   -4.5485    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   39.7768   -2.4969    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.4837   -3.7254    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.4819   -2.0881    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   41.1905   -2.4933    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.1894   -3.3185    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.8995   -3.7299    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.6153   -3.3206    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.6165   -2.4954    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.9018   -2.0795    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   41.9019   -1.2623    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.6096   -0.8537    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   43.3173   -1.2624    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.1942   -0.8537    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   39.0690   -2.0885    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.0688   -1.2713    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   43.3125   -2.0812    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   44.0193   -2.4897    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   44.7280   -2.0811    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   44.7254   -1.2597    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   44.0180   -0.8549    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   45.4305   -2.4906    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   46.1387   -2.8983    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   44.0189   -3.3069    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   43.3600   -3.7865    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   43.6121   -4.5638    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   44.4294   -4.5643    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   44.6822   -3.7872    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   44.9094   -5.2256    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   44.5767   -5.9720    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  6  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  1  9  2  0
 10  8  2  0
  8 11  1  0
 11 14  2  0
 13 12  2  0
 12 10  1  0
 13 14  1  0
 13 18  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 19 22  2  0
 10 23  1  0
 23 24  2  0
 21 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 21  1  0
 30 31  3  0
 27 30  1  0
 26 32  1  0
 32 33  1  0
 33 34  1  0
 34 35  1  0
 35 36  1  0
 36 32  1  0
 35 37  1  1
 37 38  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4571626

    ---

Associated Targets(Human)

FGFR4 Tclin Fibroblast growth factor receptor 4 (3668 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Huh-7 (12904 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Hep 3B2 (2332 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
FGFR1 Tclin Fibroblast growth factor receptor 1 (9149 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SK-HEP1 (1155 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 519.56Molecular Weight (Monoisotopic): 519.2230AlogP: 1.73#Rotatable Bonds: 6
Polar Surface Area: 140.99Molecular Species: NEUTRALHBA: 9HBD: 1
#RO5 Violations: 1HBA (Lipinski): 12HBD (Lipinski): 1#RO5 Violations (Lipinski): 2
CX Acidic pKa: 10.93CX Basic pKa: 3.85CX LogP: 1.30CX LogD: 1.30
Aromatic Rings: 2Heavy Atoms: 38QED Weighted: 0.56Np Likeness Score: -1.23

References

1. Sun C, Fang L, Zhang X, Gao P, Gou S..  (2019)  Novel 7-formyl-naphthyridyl-ureas derivatives as potential selective FGFR4 inhibitors: Design, synthesis, and biological activity studies.,  27  (10): [PMID:30987781] [10.1016/j.bmc.2019.04.018]

Source